Santé log

The Sentinel Introduces Transformative Approach to Healing in British Columbia, Setting a New Standard in Integrative Care

The Sentinel, a leading wellness centre, today announced a major initiative advancing the integration of traditional healing ...
Santé log

Fairhaven Health Develops Clinical Nutrition-Based Formulas to Support Women with PCOS and PMS

PCOS affects up to 20% of reproductive-aged women, making it one of the most prevalent endocrine disorders. However, the ...
Santé log

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, …

All Sky Premium Life products sold in the United States are manufactured locally in GMP-certified, FDA-registered, and ...
Santé log

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1

Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 ...
Santé log

Addex Appoints Bank of New York Mellon as Depositary Bank

Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today ...
Santé log

Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout

Santhera has secured a royalty monetization with existing investor R-Bridge. Pursuant to this transaction, R-Bridge will receive 25% of net royalties on AGAMREE from Catalyst (North America) and ...
Santé log

Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...
Santé log

Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced an update to the previous submission of additional clinical data to the U.S. Food and Drug Administration (FDA) from ongoing third-party ...
Santé log

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

(Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen ...
Santé log

Until Labs Announces $58M Series A Funding Round, to Develop an Organ Cryopreservation Product for Transplant Patients and Surgeons

SAN FRANCISCO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Until Labs announced today a Series A funding round of $58 million, led by Founders Fund with participation from Lux Capital and Field Ventures. The ...
Santé log

API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs

EDMONTON, Alberta and CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- This morning, at events in Edmonton and Calgary, Applied Pharmaceutical Innovation (API) proudly announced the launch of its ...
Santé log

MEDIA ADVISORY - Protests Against Ford Government’s Expanding Hospital Privatization Plans

The Ford government is privatizing our public hospitals in a move that is costing patients thousands of dollars and taking away from our local public hospital services. Everyone’s help is needed to ...